Loading patent…
AssigneesRepublic of Korea (Animal and Plant Quarantine Agency), Bioapplications Inc.
InventorsJae-Young SONG, In-Ohk OUH, Soodong CHO, Yongjik LEE, Ju-Yeon LEE, In-Soo CHO
Estimating the term…
The present invention provides: a recombinant expression vector comprising a gene encoding a porcine parvovirus VP2 protein; a recombinant plant or a recombinant insect cell transformed with the vector; and a vaccine composition for a porcine parvovirus and a composition for diagnosing porcine parvovirus, both of which contain a porcine parvovirus VP2 protein obtained from the recombinant plant or the recombinant insect cell. When the recombinant plant or recombinant insect cell of the present invention is used, the porcine parvovirus antigenic protein can be produced with high efficiency, and the porcine parvovirus antigenic protein production method using the recombinant plant or recombinant insect cell has excellent safety and stability compared with other antigen production methods.
A recombinant expression vector comprising a gene encoding a porcine parvovirus (PPV) VP2 protein, the gene being expressed by the nucleotide sequence of SEQ ID NO:
-9. (canceled)
Dependencies are inferred from the claim text.